Q3 Combined Ratio improves 317 bps to 98.9% driven by Loss Ratio moderationCHENNAI, India, Jan. 30, 2026 /PRNewswire/ -- Star Health…
Steady operating performance, innovation-driven growth, and ESG integration reinforce long-term value creationZHENGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Yutong Bus…
LAGUNA NIGUEL, Calif., Jan. 26, 2026 /PRNewswire/ -- Realty ONE Group International, a modern, purpose-driven lifestyle brand and one of…
MONTRÉAL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company”), a leading Canadian Healthtech company,…
January 27, 2026 17:10 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- In…
MUMBAI, India, Jan. 23, 2026 /PRNewswire/ -- STL (NSE: STLTECH), a leading connectivity solutions provider for AI-ready digital infrastructure, today…
MUMBAI, India, Jan. 23, 2026 /PRNewswire/ -- IIFL Finance Q3FY26 Results updateStrong rebound continues with PAT at Rs. 501 Cr,…
New findings show natural hazards such as SCS and wildfire are reshaping global loss patterns and intensifying need for both…
Sales Highlights (unaudited): Global H1 sales AUD$4.2 million up 5% on prior comparative period (pcp)Q2 sales AUD$2.2 million up 11%…
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…